Publications in collaboration with researchers from Universidade de Santiago de Compostela (29)

2024

  1. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies

    Schizophrenia Research, Vol. 268, pp. 293-301

  2. Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 135

  3. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling

    Psychiatry Research, Vol. 333

2023

  1. Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition

    Schizophrenia Research

  2. Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report

    Frontiers in Pharmacology, Vol. 14

  3. Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration

    Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34

2021

  1. Genetic diversity of drug-related genes in native americans of the brazilian amazon

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 117-133

  2. Long runs of homozygosity are associated with Alzheimer’s disease

    Translational Psychiatry, Vol. 11, Núm. 1

  3. Review of pharmacokinetics and pharmacogenetics in atypical long-acting injectable antipsychotics

    Pharmaceutics, Vol. 13, Núm. 7

2020

  1. A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations

    British Journal of Clinical Pharmacology, Vol. 86, Núm. 8, pp. 1661-1666

  2. Anti-VEGF treatment and response in age-related macular degeneration: Disease’s susceptibility, pharmacogenetics and pharmacokinetics

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 549-569

  3. Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study

    Pharmacotherapy, Vol. 40, Núm. 1, pp. 17-25

  4. The road so far in colorectal cancer pharmacogenomics: Are we closer to individualised treatment?

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-40

2019

  1. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

    Alzheimer's and Dementia, Vol. 15, Núm. 10, pp. 1333-1347

  2. Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration

    Pharmaceutics, Vol. 11, Núm. 8

2016

  1. Progress in pharmacogenetics: Consortiums and new strategies

    Drug Metabolism and Personalized Therapy, Vol. 31, Núm. 1, pp. 17-23

2015

  1. Exploration of SNP variants affecting hair colour prediction in Europeans

    International Journal of Legal Medicine, Vol. 129, Núm. 5, pp. 963-975

  2. RNA/DNA co-analysis from human skin and contact traces - Results of a sixth collaborative EDNAP exercise

    Forensic Science International: Genetics, Vol. 16, pp. 139-147

  3. The genetics of skin, hair, and eye color variation and its relevance to forensic pigmentation predictive tests

    Forensic science review, Vol. 27, Núm. 1, pp. 13-40

2014

  1. A collaborative European exercise on mRNA-based body fluid/skin typing and interpretation of DNA and RNA results

    Forensic Science International: Genetics, Vol. 10, Núm. 1, pp. 40-48